A director and 10% owner of Dell Technologies Inc., SL SPV-2, L.P., sold approximately $42.9 million worth of Class C Common Stock on September 3, 2026. The sale involved 83,066 shares at prices ranging from $514.07 to $527.7, occurring near Dell's 52-week high after a 346% gain over the past year. This transaction was part of a broader series of sales by Silver Lake entities, and comes amidst several analyst upgrades and increased price targets for Dell due to its strong performance in the AI sector.

Silver Lake Technology Investors IV, a 10% owner and director of Dell Technologies Inc. (NASDAQ:DELL), sold Class C Common Stock worth approximately $778,673 on September 3, 2026. The sale occurred after converting Class B to Class C shares. Despite the sale, Dell's stock has significantly climbed, and InvestingPro analysis suggests it is currently overvalued, although its PEG ratio indicates an attractive valuation relative to growth.

Teresa D. Bos, a director and 10% owner of OneWater Marine Inc. (NASDAQ:ONEW), sold 56,429 shares of Class A common stock for a total of $682,790 on September 4, 2026. The shares were sold at an average price of $12.10, while the stock currently trades at $11.69, despite a recent 18.56% return over six months. InvestingPro analysis suggests ONEW is undervalued, and Bos still holds substantial direct and indirect shares in the company.

Vulcan Value Partners LLC reduced its stake in NiCE by 16.4% in the second quarter, now holding 478,421 shares valued at approximately $43.47 million, which represents 1.3% of its portfolio. Despite this reduction, institutional ownership in NiCE remains substantial at 63.34%, with several other large investors increasing their positions. NiCE reported strong quarterly earnings and revenue that surpassed analyst expectations, maintaining an average analyst rating of "Hold" with a consensus price target of $129.50.

Ocugen (NASDAQ: OCGN) has successfully raised $40 million through a registered direct offering, selling 20 million shares of common stock at $2.00 each to a single institutional healthcare-focused investor. The biotech company plans to use these proceeds to fund its three late-stage gene therapy programs targeting blindness diseases, with the goal of submitting biologics license applications by 2028. This financing strengthens Ocugen's balance sheet for its capital-intensive clinical trials.

Shares of Applied Materials, AMD, Broadcom, Lam Research, and Marvell Technology surged following significant announcements in the semiconductor industry. Qualcomm partnered with AWS to develop custom AI data center infrastructure, while ASML, TSMC, and Intel made strides in next-generation chip manufacturing, including a transition to larger photomasks and processing over one million wafers with High NA EUV equipment. These advancements boosted investor confidence in future chip designs and AI infrastructure.

Methode Electronics, Inc. (MEI) reported a 10.4% increase in net sales for Q1 fiscal 2027, reaching $265.4 million, driven by higher Industrial segment volumes and new program awards totaling $400 million in lifetime revenue. Despite sales growth, the company recorded an operating loss of $3.9 million and a decline in adjusted EBITDA, raising questions about when this growth will translate into restored operating profit. While demand and bookings are improving, the conversion to consolidated earnings is not yet visible, with management emphasizing the need for successful award conversion, launch quality, and continued debt reduction to demonstrate a genuine recovery.

Western Digital's Chief Legal Officer, Cynthia L. Tregillis, sold 432 shares of common stock for $194,918 on September 4, 2026, under a Rule 10b5-1 trading plan. Despite this insider sale, InvestingPro analysis suggests Western Digital remains undervalued, with its stock showing significant momentum, including a 406% return over the past year. The company recently reported strong fiscal fourth-quarter results, although analyst opinions are mixed regarding its future prospects.

Louis Messina, Taylor Swift's tour promoter, has urged a federal judge to reject the proposed antitrust settlement between Live Nation and Ticketmaster. Messina claims that Live Nation's alleged monopolistic practices, including using ticketing fees to outbid other promoters and denying access to venues, could put him out of business. He highlights his personal experience of Live Nation stopping communication and hindering his ability to promote artists unless they used Live Nation, advocating for a different resolution to fix the "broken" music industry.

Steven Ratner, EVP and CHRO at Mercury Systems Inc. (NASDAQ:MRCY), sold 4,000 shares of company stock for approximately $338,030. The sale occurred on September 3, 2026, at an average price of $84.5076 per share. This insider transaction comes as the company's stock has declined by 6.6% over the last six months and is considered overvalued by InvestingPro analysis, despite recent strong bookings growth and raised price targets from analysts.